vs

Side-by-side financial comparison of Instil Bio, Inc. (TIL) and US ENERGY CORP (USEG). Click either name above to swap in a different company.

Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.7M, roughly 1.3× US ENERGY CORP). US ENERGY CORP runs the higher net margin — -192.2% vs -365.3%, a 173.1% gap on every dollar of revenue. On growth, Instil Bio, Inc. posted the faster year-over-year revenue change (-19.2% vs -64.9%).

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.

TIL vs USEG — Head-to-Head

Bigger by revenue
TIL
TIL
1.3× larger
TIL
$2.2M
$1.7M
USEG
Growing faster (revenue YoY)
TIL
TIL
+45.8% gap
TIL
-19.2%
-64.9%
USEG
Higher net margin
USEG
USEG
173.1% more per $
USEG
-192.2%
-365.3%
TIL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
TIL
TIL
USEG
USEG
Revenue
$2.2M
$1.7M
Net Profit
$-8.2M
$-3.3M
Gross Margin
Operating Margin
-426.3%
-194.4%
Net Margin
-365.3%
-192.2%
Revenue YoY
-19.2%
-64.9%
Net Profit YoY
31.1%
-48.7%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TIL
TIL
USEG
USEG
Q4 25
$2.2M
Q3 25
$2.2M
$1.7M
Q2 25
$2.2M
$2.0M
Q1 25
$2.2M
$2.2M
Q4 24
$2.8M
$4.2M
Q3 24
$1.5M
$5.0M
Q2 24
$0
$6.0M
Q1 24
$0
$5.4M
Net Profit
TIL
TIL
USEG
USEG
Q4 25
$-8.2M
Q3 25
$-13.6M
$-3.3M
Q2 25
$-21.4M
$-6.1M
Q1 25
$-28.2M
$-3.1M
Q4 24
$-11.9M
Q3 24
$-23.0M
$-2.2M
Q2 24
$-14.9M
$-2.0M
Q1 24
$-24.3M
$-9.5M
Operating Margin
TIL
TIL
USEG
USEG
Q4 25
-426.3%
Q3 25
-670.0%
-194.4%
Q2 25
-1045.5%
-307.6%
Q1 25
-1363.2%
-140.8%
Q4 24
-426.1%
-278.9%
Q3 24
-1582.8%
-83.8%
Q2 24
-28.4%
Q1 24
-148.8%
Net Margin
TIL
TIL
USEG
USEG
Q4 25
-365.3%
Q3 25
-606.0%
-192.2%
Q2 25
-954.2%
-298.7%
Q1 25
-1257.8%
-141.9%
Q4 24
-428.8%
Q3 24
-1541.9%
-45.3%
Q2 24
-32.6%
Q1 24
-176.9%
EPS (diluted)
TIL
TIL
USEG
USEG
Q4 25
$-1.13
Q3 25
$-2.01
Q2 25
$-3.24
$-0.19
Q1 25
$-4.32
Q4 24
$-1.82
$-0.42
Q3 24
$-3.54
$-0.08
Q2 24
$-2.29
$-0.08
Q1 24
$-3.74
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TIL
TIL
USEG
USEG
Cash + ST InvestmentsLiquidity on hand
$6.6M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$113.9M
$25.0M
Total Assets
$203.5M
$46.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TIL
TIL
USEG
USEG
Q4 25
$6.6M
Q3 25
$5.8M
$1.7M
Q2 25
$7.7M
$6.9M
Q1 25
$15.4M
$10.6M
Q4 24
$8.8M
$7.9M
Q3 24
$6.7M
$1.3M
Q2 24
$6.8M
$2.4M
Q1 24
$5.5M
$2.2M
Stockholders' Equity
TIL
TIL
USEG
USEG
Q4 25
$113.9M
Q3 25
$120.4M
$25.0M
Q2 25
$131.7M
$28.0M
Q1 25
$144.9M
$33.6M
Q4 24
$169.4M
$24.2M
Q3 24
$176.3M
$35.7M
Q2 24
$195.0M
$37.7M
Q1 24
$205.8M
$36.7M
Total Assets
TIL
TIL
USEG
USEG
Q4 25
$203.5M
Q3 25
$211.8M
$46.5M
Q2 25
$231.0M
$51.0M
Q1 25
$237.4M
$55.8M
Q4 24
$263.6M
$49.7M
Q3 24
$272.6M
$64.1M
Q2 24
$294.3M
$73.7M
Q1 24
$306.3M
$70.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TIL
TIL
USEG
USEG
Operating Cash FlowLast quarter
$-7.1M
$-155.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TIL
TIL
USEG
USEG
Q4 25
$-7.1M
Q3 25
$-10.6M
$-155.0K
Q2 25
$-14.8M
$-1.6M
Q1 25
$-4.2M
$-4.5M
Q4 24
$-10.6M
$1.7M
Q3 24
$-20.1M
$2.6M
Q2 24
$-10.6M
$929.0K
Q1 24
$-14.4M
$-603.0K
Capex Intensity
TIL
TIL
USEG
USEG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TIL
TIL

Segment breakdown not available.

USEG
USEG

Oil Sales$1.6M91%
Other$151.0K9%

Related Comparisons